The new EU HTA procedure will significantly change the requirements before placing innovative medicinal products on the EU market, with certain new products having to go through a joint European assessment as a first step. SOBI’s Ana Palma and EUCOPE’s Alexander Natz join our latest podcast to examine the implications for health technology developers and patients before the first medicinal products will be subject to the new procedure in 2025.
🎧LISTEN NOW:
#Spotify – https://open.spotify.com/episode/0djxipREuRkrGDDJHnc0BW?si=H24eXrOETlivjzgcWuUCJQ
#Applepodcasts – https://podcasts.apple.com/be/podcast/the-new-eu-hta-procedure-getting-it-right-to-improve/id1562066466?i=1000597308769
#Anchorfm – https://spotifyanchor-web.app.link/e/2dETGAC61wb